Related Experiment Video

Updated: Jul 15, 2026

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal
11:21

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal

Published on: January 26, 2019

Research advances in apoptosis-mediated cancer therapy: a review

Antonio Lopez-Beltran1, Gregory T Maclennan, Juan de la Haba-Rodriguez

  • 1Unit of Anatomic Pathology, Cordoba University Medical School, Reina Sofia University Hospital, Cordoba, Spain. em1lobea@uco.es

Analytical and Quantitative Cytology and Histology
|May 9, 2007
PubMed

Insights

Cancer cells often evade programmed cell death (apoptosis), creating a clinical challenge. Researchers are developing novel cancer therapies by targeting the apoptotic signaling pathways to re-sensitize tumors to cell death.

Area of Science:

  • Biomedical Sciences
  • Molecular Biology
  • Oncology

Background:

  • Apoptosis, or programmed cell death, is crucial for tissue homeostasis.
  • Cancer cells frequently develop resistance to apoptosis, contributing to tumor progression and treatment failure.
  • Understanding apoptosis evasion mechanisms is vital for developing effective cancer therapies.

Purpose of the Study:

  • To review recent advancements in targeting apoptosis for cancer therapy.
  • To highlight therapeutic strategies focused on modulating apoptotic pathways in malignant cells.
  • To summarize current research on apoptosis-mediated cancer treatments.

Main Methods:

  • Literature review of recent research developments.
  • Analysis of therapeutic compounds targeting apoptotic signaling pathways.
  • Examination of clinical trial data for apoptosis-targeting drugs.

Main Results:

  • Malignant cells' ability to evade apoptosis is a key factor in cancer development.
  • Targeting apoptotic machinery or growth factor signaling shows promise in preclinical and clinical studies.
  • Several novel therapeutic compounds are in clinical trials for cancer treatment.

Conclusions:

  • Targeting apoptosis represents a promising strategy for overcoming cancer's resistance to cell death.
  • Further research into apoptosis-mediated cancer therapy could lead to more effective treatments.
  • Developing drugs that induce apoptosis in cancer cells is a critical area of oncology research.

More Related Videos

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...